The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability

被引:59
作者
Jarvis, William R. [1 ]
机构
[1] Jason & Jarvis Associates, Hilton Head Isl, SC USA
关键词
nosocomial infections; healthcare-associated infections; infection control; prevention;
D O I
10.1016/S0195-6701(07)60005-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Approximately 2,000,000 healthcare-associated infections (HAIs) annually occur in US healthcare facilities and lead to approximately 60,000 90,000 deaths and cost $17 29 billion dollars. Such HAIs are an equal, if not more common problem, worldwide. Many evidence-based HAI prevention guidelines exist. However, despite knowing what to do, the challenge remains of getting clinicians to comply with these recommendations. In the USA, a variety of forces, including the public and legislators, are demanding HAI prevention. This is illustrated by the Consumers Union's effort to get legislation in every state for public HAI rate reporting. In addition, a number of profit-making and non-profit-making organizations have initiated major HAI prevention interventions. At least three common themes for these interventions exist. First, no single intervention prevents any HAI; rather a "bundle" approach, using a package of multiple interventions based on evidence provided by the infection control community and implemented by a multidisciplinary team is the model for successful HAI prevention. Second, benchmarking is inadequate and a culture of zero tolerance is required. Third, a culture of accountability and administrative support is required. Such interventions have illustrated that much greater levels of HAI prevention can be accomplished than ever estimated in the past. Implementation of evidence-based HAI prevention interventions should be a high priority for all healthcare facilities to reduce preventable HAIs to the greatest extent possible. © 2007 The Hospital Infection Society.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 30 条
[1]   Eliminating catheter-related bloodstream infections in the intensive care unit [J].
Berenholtz, SM ;
Pronovost, PJ ;
Lipsett, PA ;
Hobson, D ;
Earsing, K ;
Farley, JE ;
Milanovich, S ;
Garrett-Mayer, E ;
Winters, BD ;
Rubin, HR ;
Dorman, T ;
Perl, TM .
CRITICAL CARE MEDICINE, 2004, 32 (10) :2014-2020
[2]   Effects of nosocomial candidemia on outcomes of critically ill patients [J].
Blot, SI ;
Vandewoude, KH ;
Hoste, EA ;
Colardyn, FA .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (06) :480-485
[3]  
Bratzler DW, 2006, AM SURGEON, V72, P1010
[4]   Use of antimicrobial prophylaxis for major surgery - Baseline results from The National Surgical Infection Prevention Project [J].
Bratzler, DW ;
Houck, PM ;
Richards, C ;
Steele, L ;
Dellinger, EP ;
Fry, DE ;
Wright, C ;
Ma, A ;
Carr, K ;
Red, L .
ARCHIVES OF SURGERY, 2005, 140 (02) :174-182
[5]   Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: One-year outcomes and lessons learned [J].
Burns, SM ;
Earven, S ;
Fisher, C ;
Lewis, R ;
Merrell, P ;
Schubart, JR ;
Truwit, JD ;
Bleck, TP .
CRITICAL CARE MEDICINE, 2003, 31 (12) :2752-2763
[6]   Long-term reduction of vascular access-associated bloodstream infection [J].
Eggimann, P ;
Hugonnet, SP ;
Sax, H ;
Harbarth, S ;
Chevrolet, JC ;
Pittet, D .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) :875-876
[7]   What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists):: A review and an au revoir [J].
Farr, Barry M. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (10) :1096-1106
[8]   A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: A prospective, randomized trial [J].
Garland, JS ;
Alex, CP ;
Henrickson, KJ ;
McAuliffe, TL ;
Maki, DG .
PEDIATRICS, 2005, 116 (02) :E198-E205
[9]   Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial [J].
Henrickson, KJ ;
Axtell, RA ;
Hoover, SM ;
Kuhn, SM ;
Pritchett, J ;
Kehl, SC ;
Klein, JP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1269-1278
[10]   Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia [J].
Huang, Susan S. ;
Yokoe, Deborah S. ;
Hinrichsen, Virginia L. ;
Spurchise, Laura S. ;
Datta, Rupak ;
Miroshnik, Irina ;
Platt, Richard .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (08) :971-978